logo
  

Triumph To Assume Production Of Gulfstream G650, G280 Wing Programs From Spirit

Triumph Group Inc. (TGI) Tuesday announced the signing of a definitive agreement with Spirit AeroSystems Holdings, Inc. (SPR) for Triumph to take over production of the Gulfstream G650 and G280 wing programs located in Tulsa, Oklahoma. The transaction is targeted to close by calendar year end.

Triumph will receive $160 million in cash plus assets required to run the business from Spirit to cover the expected future cash flow needs of the programs. Triumph expects no additional capital contributions.

The company expects the programs to be initially cash flow negative, with operating cash requirements anticipated to decrease over the first three years and becoming cash flow positive in the fourth year.

The business will be included in the Aerostructures Group segment and is expected to add around $250 million in annual revenue and to be immediately accretive to Triumph's earnings per share upon closing.

After the close of the transaction, production will continue out of Spirit's Tulsa facility and Triumph will look to utilize its manufacturing experience, resources and wing design engineering capabilities to supplement the Tulsa operations.

The company will focus on optimizing the build process and cost structure of the programs, and has identified opportunities for engineering, supply chain and labor enhancements.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Lincoln Park, New Jersey -based ConSup North America Inc. is recalling around 85,984 pounds of ready-to-eat or RTE sliced prosciutto ham product produced in Germany without the benefit of equivalent inspection, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and...

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT